These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 1853639
41. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Begley DJ. Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907 [Abstract] [Full Text] [Related]
42. [Structural basics for development of blood-cerebrospinal fluid barrier in man]. Korzhevskiĭ DE, Otellin VA. Usp Fiziol Nauk; 2002 Oct; 33(4):43-52. PubMed ID: 12449806 [Abstract] [Full Text] [Related]
43. [The permeability of the hemato-encephalic barrier in neurological cancer patients in the postoperative period]. Kislitsyn IuV. Zh Vopr Neirokhir Im N N Burdenko; 1999 Oct; (1):25-7; discussion 27-8. PubMed ID: 10335573 [Abstract] [Full Text] [Related]
44. [Blood-brain and blood-cerebrospinal fluid barriers under physiological conditions and in inflammatory states of the central nervous system]. Majchrowicz H. Przegl Epidemiol; 1983 Oct; 37(3-4):403-7. PubMed ID: 6665198 [No Abstract] [Full Text] [Related]
45. Breaching the barrier. Dove A. Nat Biotechnol; 2008 Nov; 26(11):1213-5. PubMed ID: 18997754 [No Abstract] [Full Text] [Related]
48. Detoxification systems, passive and specific transport for drugs at the blood-CSF barrier in normal and pathological situations. Strazielle N, Khuth ST, Ghersi-Egea JF. Adv Drug Deliv Rev; 2004 Oct 14; 56(12):1717-40. PubMed ID: 15381331 [Abstract] [Full Text] [Related]
49. Peptide and peptide analog transport systems at the blood-CSF barrier. Smith DE, Johanson CE, Keep RF. Adv Drug Deliv Rev; 2004 Oct 14; 56(12):1765-91. PubMed ID: 15381333 [Abstract] [Full Text] [Related]
51. [Characteristics of the transport of structural analogs of thyroid hormone through hemato-encephalic barrier]. Dembri A. C R Seances Soc Biol Fil; 1987 Oct 14; 181(3):249-57. PubMed ID: 2958113 [Abstract] [Full Text] [Related]
52. Deoxynucleoside and vitamin transport into the central nervous system. Spector R, Eells J. Fed Proc; 1984 Feb 14; 43(2):196-200. PubMed ID: 6692939 [Abstract] [Full Text] [Related]
53. Quantitative studies of the passage of different substances out of the cerebrospinal fluid. DAVSON H, KLEEMAN CR, LEVIN E. J Physiol; 1962 Apr 14; 161(1):126-42. PubMed ID: 13883991 [No Abstract] [Full Text] [Related]
54. The turnover of 24Na in the cerebrospinal fluid and its bearing on the blood-brain barrier. DAVSON H, POLLAY M. J Physiol; 1963 Jul 14; 167(2):247-55. PubMed ID: 14025546 [No Abstract] [Full Text] [Related]
55. [Adrenomedullin in the central nervous system]. Ueta Y. Nihon Rinsho; 2004 Sep 14; 62 Suppl 9():246-51. PubMed ID: 15506379 [No Abstract] [Full Text] [Related]
56. Effect of hypothermia on certain aspects of the cerebrospinal fluid. DAVSON H, SPAZIANI E. Exp Neurol; 1962 Aug 14; 6():118-28. PubMed ID: 13883992 [No Abstract] [Full Text] [Related]
58. [Permeability of the hemato-encephalic barrier and the blood-cerebrospinal fluid barrier in experimental meningitis and in fever]. FINCK W. Zentralbl Allg Pathol; 1957 Aug 26; 96(9-11):477-83. PubMed ID: 13497032 [No Abstract] [Full Text] [Related]
59. [The blood brain barrier-barrier or wall?]. Med Periskop Ingelheim; 1961 Jun 26; 11():73-8. PubMed ID: 14448120 [No Abstract] [Full Text] [Related]
60. The ground substance of the central nervous system and its relation to the blood-brain barrier. HESS A. World Neurol; 1962 Feb 26; 3():118-24. PubMed ID: 13906985 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]